Navigation Links
Wisconsin VCs draw Missouri biotech firm to state

The Milwaukee County Research Park Center. ZyStor will have labs at the research park.
An investment of $8.5 million from a venture-capital syndicate has drawn a St. Louis niche-market biotech company to Wisconsin, where it will inhabit brand-new lab facilities at Milwaukee County Research Park.

The ......

Full article >>> CEO Loren G. Peterson said. Peterson, Chief Scientific Officer Jonathan H. LeBowitz and another senior scientist are moving to Wisconsin, where they expect to hire about 7 people over the next six months. Broderick said the company might employ as many as 20 in a few years.

The venture group, in addition to Mason Wells, includes Ve......

Full article >>> nzyme is the 800-pound gorilla in the space, said Chris Raymond, an analyst with Robert W. Baird & Co. Inc. Its 12-year-old drug for Gauchers disease, a better-known lysosomal condition, pulls in about $800 million a year, he said. Thats because the cost of a years treatment is about $160,000.

Pompe disease is newer and not as well under......

Full article >>> esearch Park edged it out on factors such as proximity to the Medical College of Wisconsin, Broderick said.

The two communities are close enough that there are still opportunities to be part of the synergy of Madisons life sciences, Arida said.

-----
Jason Stitt is WTNs associate editor and can be reached at

Source:wistechnology.com By Jason Stitt 11/05/04


Related biology technology :

1. To be a player in the "Knowledge Economy," Wisconsin needs more tech workers
2. Federal bioenergy lab will give Wisconsin a chance to shine
3. Breaking down Wisconsins angel capital numbers
4. Innovation featured in NE Wisconsin Roundtable
5. Visions: Broderick says Wisconsin should be in top third in venture capital
6. Wisconsin building toward the major leagues of venture capital
7. Wisconsin Supreme Court to hear Menasha software case
8. Wisconsin applicants urged to pursue DOE funding for cellulosic biomass
9. Legislature should look to Wisconsins natural energy advantages
10. Stem cells get most attention, but they are only part of Wisconsins bio-portfolio
11. BIO 2007: Wisconsin makes its presence felt
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... -- Financial Highlights ... unaudited)Three Months Ended December 31,Twelve Months Ended December 31,20162015% ... $           300$   ... Product Revenue 3539(10)%9498(4)%Kuvan Net Product ... 756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... TORONTO , Feb. 23, 2017 /PRNewswire/ - The ... Institute for Cancer Research (OICR) are pleased to report ... Series A financing, with Johnson & Johnson Innovation – ... investors include venture groups HealthCap, TPG Biotechnology Partners, and ... ...
(Date:2/23/2017)... it seems everyone has a chance to express their personalities. ... and dynamic community unlike any other. The businesses that succeed ... With their newest salon in Dunwoody ... that tradition with a unique, fresh approach to head lice ... newest of 13 nationwide locations, each of them well-situated in ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life ... product line of oncolytic vaccinia viruses for virotherapy ... as part of Genelux,s proprietary, vaccinia virus-based technology ... excited to enter into a partnership with Genelux ... oncolytic vaccinia viruses for use in research," said ...
Breaking Biology Technology:
(Date:2/7/2017)... Feb. 7, 2017   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... its innovative, highly flexible and award winning eClinical solution, ... iMedNet is a proven Software-as-a-Service (SaaS) clinical ... Capture (EDC), but also delivers an entire suite of ...
(Date:2/6/2017)... , Feb. 6, 2017 According ... security are driving border authorities to continue to ... reports there are 2143 Automated Border Control (ABC) ... currently deployed at more than 163 ports of ... 2013 to 2016 achieving a combined CAGR of ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
Breaking Biology News(10 mins):